These results demonstrate that the pro-apoptotic effects of miR-29a/b/c require the presence of wild-type p53 and that miR-29a/b/c induce the apoptosis of glioma cells via the AKT/MDM2/p53 pathway in a p53-dependent manner (Fig. 8c). Here, TP53 is linked to glioma.